Loading...
Products:Neuroscience >> Cell Type Marker >> Neuron marker >> Growth Cone
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-Agrin antibody [Agr 247]
See all Agrin products (3) ...
Mouse monoclonal [Agr 247] to Agrin
Ab12364 regognises agrin.
ICCmore details
Reacts with
Mouse, Rat
Recombinant rat agrin, C-terminal construct.
Ab12364 binds to an epitope close to splicing site Z and causes a marked reduction in the number of nicotinic acetylcholine receptor(nAChR) clusters in samples from mouse and rat origins.
Mouse Brain Tissue Extract.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.09% Sodium Azide
Constituents: 50% Glycerol, PBS
Concentration information loading...
Protein G purified
Monoclonal
Agr 247
IgG1
Neuroscience >> Neurology process >> Neural Signal Transduction
Neuroscience >> Cell Adhesion Proteins >> ECM Proteins
Neuroscience >> Cell Type Marker >> Neuron marker >> Growth Cone
Our Abpromise guarantee covers the use of ab12364 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC: Use a concentration of 2 µg/ml.
Agrin is an essential extracellular matrix component which promotes clustering of nicotinic acetylcholine receptors (nAChRs) and other proteins during development at the neuromuscular junction. Agrin, MuSK and Rapsyn are all essential components for AChR aggregation, through an unknown mechanism. The C-terminal region of agrin is released into the medium, interacts with receptors on the muscle surface and induces AChR aggregation. The central region contains two O-linked glycosylation sites and a domain homologous to domain III of laminin. The N-terminal region anchors agrin to the extracellular matrix via other basal membrane components. This region also contains a protease inhibitor domain and glycosaminoglycan attachment sites; increasing the predicted MW from 200kDa to ~600kDa.
Secreted; extracellular space; extracellular matrix. Note: Synaptic basal lamina at the neuromuscular junction.
This product has been referenced in:
See 1 publication for this product
Publishing research using ab12364? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
